Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb 12;43(7):699-700.
doi: 10.1093/eurheartj/ehab681.

Reporting data from meta-analysis: snapshot of a moving target

Affiliations
Comment

Reporting data from meta-analysis: snapshot of a moving target

Yousif Ahmad et al. Eur Heart J. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Berry C. Meta-analyses of moving targets. Eur Heart J 2021;42:2655–2656. - PMC - PubMed
    1. Pilgrim T, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, Weilenmann D, Kaiser C, Tapponnier M, Losdat S, Eeckhout E, Valgimigli M, Jüni P, Windecker S, Iglesias JF. Biodegradable- versus durable-polymer drug-eluting stents for STEMI: final 2-year outcomes of the BIOSTEMI trial. JACC Cardiovasc Interv 2021;14:639–648. - PubMed
    1. Gao C, Kogame N, Sharif F, Smits PC, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Zaman A, de Winter RJ, Onuma Y, Serruys PW. Prospective multicenter randomized all-comers trial to assess the safety and effectiveness of the ultra-thin strut sirolimus-eluting coronary stent supraflex: two-year outcomes of the TALENT trial. Circ Cardiovasc Interv 2021;14:e010312. - PubMed
    1. Madhavan MV, Howard JP, Naqvi A, Ben-Yehuda O, Redfors B, Prasad M, Shahim B, Leon MB, Bangalore S, Stone GW, Ahmad Y. Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J 2021;42:2643–2654. - PMC - PubMed

Publication types